Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

NICE shoots down Bayer's Stivarga in liver cancer, citing price, clinical questions

fiercepharmaNovember 09, 2017

Tag: NICE , Bayer , Liver cancer

PharmaSources Customer Service